CCS: Cervical Cancer Screening
Pap test within 3 years (21-29) OR Pap+HPV co-test within 5 years (30-64).
Measure description
Pap test within 3 years (21-29) OR Pap+HPV co-test within 5 years (30-64).
Eligible population
Women 21-64
Performance drivers
USPSTF aligned. Star measure.
Documentation & PA strategy
PA not required for screening. Document Pap (88142/88175) + HPV (87624) co-test for ages 30+.
Why HEDIS matters for prior authorization
Health plans align prior authorization criteria with HEDIS measures: documenting your patient meets the HEDIS definition often streamlines or eliminates PA hurdles. For Medicare Advantage in particular, plans are heavily incentivized via Star Ratings to push members and providers toward measure compliance, which translates into faster approvals for measure-aligned services.
Frequently asked questions
What does HEDIS measure CCS measure?
Pap test within 3 years (21-29) OR Pap+HPV co-test within 5 years (30-64).
What drives performance on this measure?
USPSTF aligned. Star measure.
How should clinicians document for this measure?
PA not required for screening. Document Pap (88142/88175) + HPV (87624) co-test for ages 30+.
What is the eligible population?
Women 21-64
Streamline CCS workflow with ApprovalHelp
ApprovalHelp automates clinical PA, appeals, and HEDIS-aligned documentation. no setup fee.
Get started →Contact: hello@approvalhelp.com